Page last updated: 2024-10-30

leflunomide and Laryngeal Diseases

leflunomide has been researched along with Laryngeal Diseases in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Laryngeal Diseases: Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.

Research Excerpts

ExcerptRelevanceReference
"Rheumatoid nodules are common extra-articular findings occurring in 20% RA patients."2.43Laryngeal involvement in rheumatoid arthritis. ( Assimakopoulos, D; Bai, M; Drosos, AA; Papazisi, D; Voulgari, PV; Zagorianakou, P, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Voulgari, PV1
Papazisi, D1
Bai, M1
Zagorianakou, P1
Assimakopoulos, D1
Drosos, AA1

Reviews

1 review available for leflunomide and Laryngeal Diseases

ArticleYear
Laryngeal involvement in rheumatoid arthritis.
    Rheumatology international, 2005, Volume: 25, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Arytenoid Cartilage; Cricoid Cartilage; Cyclosporine; Drug Therapy,

2005